Home > Pharmacy guidance on smoking and mental disorder.

Campion, Jonathan and Hewitt, Jed and Shiers, David and Taylor, David . (2017) Pharmacy guidance on smoking and mental disorder. London: Royal College of Psychiatrists, National Pharmacy Association and Royal Pharmaceutical Society. 4 p.

[img]
Preview
PDF (Pharmacy guidance on smoking)
533kB

• Smoking is the single largest cause of preventable death in the UK and a major determinant of health inequality for those with a mental disorder.
• With appropriate support, those with a mental disorder are able to stop smoking.
• Doses of some psychiatric medication require significant reduction following smoking cessation.
• A range of pharmacological interventions (such as combination nicotine replacement therapy or varenicline) and non-pharmacological interventions are effective in supporting smoking cessation for people with a mental disorder.
• Pharmacists have a key role in improving access to smoking cessation and reduction interventions for smokers with a mental disorder as well as facilitating appropriate changes of medication doses.

Pharmacists are ideally placed:
• to encourage patients to stop smoking,
• to explain the benefits of smoking cessation
• to support smoking reduction as a first step to cessation promoting a healthier lifestyle
• to counsel patients on the lifestyle change
• to facilitate change to patients’ medication doses where appropriate


Item Type:Evidence resource
Publication Type:Report
Drug Type:Tobacco
Intervention Type:AOD disorder, AOD prevention, AOD disorder harm reduction
Date:April 2017
Pages:4 p.
Publisher:Royal College of Psychiatrists, National Pharmacy Association and Royal Pharmaceutical Society
Place of Publication:London
EndNote:View
Related URLs:
Subjects:B Substances > Tobacco (cigarette smoking)
J Health care, prevention and rehabilitation > Care by type of problem > Mental health care
T Demographic characteristics > Pharmacist
VA Geographic area > Europe > United Kingdom

Repository Staff Only: item control page